← back to search

Sisi Wei

Shanghai Children's Hospital · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer-related molecular mechanisms research, Cancer, Hypoxia, and Metabolism, RNA modifications and cancer, and Ferroptosis and cancer prognosis.
h-index
14
citations
730
works
66
NIH funding
primary concept
email

Recent publications

<scp>IFI30</scp> Knockdown Inhibits <scp>ESCC</scp> Progression by Promoting Apoptosis and Senescence via Activation of <scp>JNK</scp> and <scp>P21</scp>/<scp>P16</scp> Pathways
Thoracic Cancer 2025cited by 1position: middledoi
GRHL3 specifically initiated by the TP63 transcription factor promotes the metastasis of squamous cell carcinogenesis
Cellular Signalling 2025cited by 1position: middledoi
CMSP exerts anti-tumor effects on small cell lung cancer cells by inducing mitochondrial dysfunction and ferroptosis
Open Medicine 2025cited by 0position: middledoi
H-chain ferritin-based magnetic nanoparticles targeting CD71 for magnetic resonance imaging diagnosis of esophageal squamous cell carcinoma and its precancerous lesions
International Journal of Biological Macromolecules 2025cited by 0position: middledoi
A Novel Autophagy Inhibitor <i>p</i> -Hydroxylcinnamaldehyde Suppresses Esophageal Squamous Cell Carcinoma by Targeting LDHA Phosphorylation-Mediated Metabolic Reprogramming
Research 2025cited by 0position: firstdoi
The impact of glucose metabolism on inflammatory processes in sepsis-induced acute lung injury
Frontiers in Immunology 2024cited by 27position: middledoi
Periplcymarin targets glycolysis and mitochondrial oxidative phosphorylation of esophageal squamous cell carcinoma: Implication in anti-cancer therapy
Phytomedicine 2024cited by 13position: middledoi
NEK2 Promotes ESCC Malignant Progression by Inhibiting Cellular Senescence via the FOXM1/c‐Myc/p27 Signaling Pathway
Molecular Carcinogenesis 2024cited by 7position: middledoi
Hypoxia Induced <i>Lnc191</i> Upregulation Dictates the Progression of Esophageal Squamous Cell Carcinoma by Activating GRP78/ERK Pathway
Advanced Science 2024cited by 5position: firstdoi
The NR_109/FUBP1/c-Myc axis regulates TAM polarization and remodels the tumor microenvironment to promote cancer development
Journal for ImmunoTherapy of Cancer 2023cited by 77position: middledoi
Combination of size‐exclusion chromatography and ion exchange adsorption for improving the proteomic analysis of plasma‐derived extracellular vesicles
PROTEOMICS 2023cited by 17position: middledoi
P-Hydroxylcinnamaldehyde induces tumor-associated macrophage polarization toward the M1 type by regulating the proteome and inhibits ESCC in vivo and in vitro
International Immunopharmacology 2023cited by 11position: middledoi
LncRNA SNHG5 Suppresses Cell Migration and Invasion of Human Lung Adenocarcinoma via Regulation of Epithelial-Mesenchymal Transition
Journal of Oncology 2023cited by 9position: middledoi
Potential ‘anti-cancer’ effects of esketamine on proliferation, apoptosis, migration and invasion in esophageal squamous carcinoma cells
European journal of medical research 2023cited by 7position: middledoi
Ropivacaine inhibits the malignant behavior of lung cancer cells by regulating retinoblastoma-binding protein 4
PeerJ 2023cited by 5position: middledoi
SF3B4 Regulated Alternative Splicing that Produced an Oncogenic Isoform of HOXA11-AS to Promote Glycolytic Reprogramming and ESCC Progression
Research Square 2023cited by 0position: middledoi
ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma
BioMed Research International 2022cited by 13position: middledoi
Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer
Frontiers in Genetics 2022cited by 9position: middledoi
Extracellular vesicles isolated by size-exclusion chromatography present suitability for RNomics analysis in plasma
Journal of Translational Medicine 2021cited by 90position: middledoi
Outer Membrane Vesicles Secreted by <i>Helicobacter pylori</i> Transmitting Gastric Pathogenic Virulence Factors
ACS Omega 2021cited by 33position: firstdoi
SNORA42 promotes oesophageal squamous cell carcinoma development through triggering the DHX9/p65 axis
Genomics 2021cited by 15position: middledoi
LncRNA NR038975, A Serum-Based Biomarker, Promotes Gastric Tumorigenesis by Interacting With NF90/NF45 Complex
Frontiers in Oncology 2021cited by 12position: firstdoi
Inhibitory Effects of Periplocin on Lymphoma Cells: A Network Pharmacology Approach and Experimental Validation
Drug Design Development and Therapy 2021cited by 5position: middledoi
SNHG5 inhibits the progression of EMT through the ubiquitin-degradation of MTA2 in oesophageal cancer
Carcinogenesis 2020cited by 20position: firstdoi
MTA2 promotes the metastasis of esophageal squamous cell carcinoma via EIF4E‐Twist feedback loop
Cancer Science 2020cited by 12position: middledoi
Metastasis-associated protein 2 (MTA2) promotes the metastasis of esophageal squamous cell carcinoma via EIF4E-Twist feedback loop
Research Square (Research Square) 2020cited by 0position: middledoi
SNORA42 Promote Oesophageal Squamous Cell Carcinoma Development Through Interacting With Dhx9
Research Square (Research Square) 2020cited by 0position: middledoi
Combination of the natural compound Periplocin and TRAIL induce esophageal squamous cell carcinoma apoptosis in vitro and in vivo: Implication in anticancer therapy
Journal of Experimental & Clinical Cancer Research 2019cited by 33position: middledoi
lncRNA SNHG5 Modulates Endometrial Cancer Progression via the miR-25-3p/BTG2 Axis
Journal of Oncology 2019cited by 19position: middledoi
p-Hydroxylcinnamaldehyde from cochinchinamomordica seed reverses resistance to TRAIL in human oesophageal squamous cell carcinoma via the activation of the p38 mitogen-activated protein kinase signalling pathway
Biomedicine & Pharmacotherapy 2019cited by 7position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Suli Dai · Hebei Medical University23 papers (2019–2025)Lianmei Zhao · Hebei Medical University19 papers (2019–2025)Baoen Shan · Hebei Medical University14 papers (2019–2025)Xiaoya Li · Nanjing Medical University9 papers (2019–2025)Lianmei Zhao · Hebei Medical University8 papers (2019–2025)Yaojie Wang · Northwestern University8 papers (2019–2025)Cong Zhang · Hebei Medical University7 papers (2019–2025)Huilai Lv · Hebei Medical University6 papers (2020–2024)Yueping Liu · Hebei Medical University5 papers (2020–2024)Cong Zhang · Army Medical University5 papers (2019–2023)Xiaohan Xiang · Hebei Medical University4 papers (2019–2024)Ruinian Zhao · Hebei Medical University4 papers (2019–2021)Yuhui Fu · Civil Aviation University of China4 papers (2024–2025)Riyang Zhao · Hebei Medical University4 papers (2019–2021)Baoen Shan · Harbin Engineering University3 papers (2020–2025)Lujuan Han · Hebei Medical University3 papers (2019–2024)Cong Zhang · Hebei Medical University3 papers (2019–2024)Cong Zhang · Soochow University3 papers (2023–2023)Zhirong Li · Hebei Medical University3 papers (2019–2023)X.Q. Deng · OriginWater (China)2 papers (2019–2021)